Retatrutide high purity 99% white raw powder
TDS
21744-84-3
Industrial Grade
99%
Shenzhen
subi
5/10/15mg*10vials
2026-01-31
peptone
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial Reference4-Methyl-2H-1,4-benzoxazin-3(4H)-one is a heterocyclic building block. ItsC-formylation in the presence of 1,1-dichloromethyl methyl ether under Friedel-Crafts reaction conditions has been reported.Certificates
-
TDS
Basic Info-
Product Name:
4-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE
Other Name:BUTTPARK 148\07-41;4-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE;4-METHYLBENZO[B]MORPHOLIN-3-ONE;4-(N-METHYL)-1,4-BENZOXAZINE-3-ONE;4-METHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE, 98 %;4-Methyl-2H-1,4-Benzoxazin-3-one;4-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one;JR-8987, 4-Methyl-2H-1,4-benzoxazin-3-(4H)-one, 97%
CAS No.:21744-84-3
Molecular Formula:C9H9NO2
InChIKeys:DBJMEBUKQVZWMD-UHFFFAOYSA-N
Molecular Weight:163.17
Exact Mass:163.17
DSSTox ID:DTXSID30176141
HScode:2934999090
Categories:
Characteristics-
Density:
1.209±0.06 g/cm3(Predicted)
Melting Point:57-60 °C (lit.)
Boiling Point:369.5±31.0 °C(Predicted)
Water Solubility:0.01 M
PKA:1.49±0.20(Predicted)
Critical Temperature & Pressure:Sealed in dry,Room Temperature
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptone
-
Location:
Room A109, No. 29 Dongting Road, Hexi District, Tianjin
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
3
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2024
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product